Click for best price
siRNA Drugs Market Size, Share 2023
This report contains market size and forecasts of siRNA Drugs in Global, including the following market information:
Global siRNA Drugs Market Size 2024-2032, ($ millions)
The global siRNA Drugs market is projected to reach US$ million by 2032.
We surveyed the siRNA Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global siRNA Drugs Market, by Type, 2024-2032 ($ millions)
Global siRNA Drugs Market Segment Percentages, by Type
Without GalNAc-conjugated
With GalNAc-conjugated
Global siRNA Drugs Market, by Application, 2024-2032 ($ millions)
Global siRNA Drugs Market Segment Percentages, by Application
Genetic Disease
Cancers
Other
Global siRNA Drugs Market, By Region and Country, 2024-2032 ($ Millions)
Global siRNA Drugs Market Segment Percentages, by region and country
United States
Europe
Asia
China
Rest of World
Competitor Analysis
The report also provides analysis of leading market participants including:
Further, the report presents profiles of competitors in the market, key players include:
Alnylam
Novartis
Sirnaomics
Ribo Life Science
| Report Attributes |
Report Details |
| Report Title |
siRNA Drugs Market, Global Outlook and Forecast 2023-2032 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
64 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 siRNA Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global siRNA Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global siRNA Drugs Overall Market Size
2.1 Global siRNA Drugs Market Size: 2023 VS 2032
2.2 Global siRNA Drugs Market Size, Prospects & Forecasts: 2023-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Key siRNA Drugs Players in Global Market
3.2 Global Companies siRNA Drugs Product & Technology
4 siRNA Drugs Companies Profiles
4.1 Alnylam
4.1.1 Alnylam Company Summary
4.1.2 Alnylam Business Overview
4.1.3 Alnylam siRNA Drugs Product Offerings & Technology
4.1.4 Alnylam siRNA Drugs R&D, and Plans
4.2 Novartis
4.2.1 Novartis Company Summary
4.2.2 Novartis Business Overview
4.2.3 Novartis siRNA Drugs Product Offerings & Technology
4.2.4 Novartis siRNA Drugs R&D, and Plans
4.3 Sirnaomics
4.3.1 Sirnaomics Company Summary
4.3.2 Sirnaomics Business Overview
4.3.3 Sirnaomics siRNA Drugs Product Offerings & Technology
4.3.4 Sirnaomics siRNA Drugs R&D, and Plans
4.4 Ribo Life Science
4.4.1 Ribo Life Science Company Summary
4.4.2 Ribo Life Science Business Overview
4.4.3 Ribo Life Science siRNA Drugs Product Offerings & Technology
4.4.4 Ribo Life Science siRNA Drugs R&D, and Plans
5 Sights by Region
5.1 By Region - Global siRNA Drugs Market Size, 2024 & 2032
5.2 By Region - Global siRNA Drugs Revenue, (2024-2032)
5.3 United States
5.3.1 Key Players of siRNA Drugs in United States
5.3.2 United States siRNA Drugs Development Current Situation and Forecast
5.4 Europe
5.4.1 Key Players of siRNA Drugs in Europe
5.4.2 Europe siRNA Drugs Development Current Situation and Forecast
5.5 China
5.5.1 Key Players of siRNA Drugs in China
5.5.2 China siRNA Drugs Development Current Situation and Forecast
5.6 Rest of World
6 Sights by Product
6.1 By Type - Global siRNA Drugs Market Size Markets, 2024 & 2032
6.2 Without GalNAc-conjugated
6.3 With GalNAc-conjugated
7 Sights by Application
7.1 By Application - Global siRNA Drugs Market Size, 2024 & 2032
7.2 Genetic Disease
7.3 Cancers
7.4 Other
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. siRNA Drugs Market Opportunities & Trends in Global Market
Table 2. siRNA Drugs Market Drivers in Global Market
Table 3. siRNA Drugs Market Restraints in Global Market
Table 4. Key Players of siRNA Drugs in Global Market
Table 5. Global Companies siRNA Drugs Product & Technology
Table 6. Alnylam Company Summary
Table 7. Alnylam siRNA Drugs Product Offerings
Table 8. Novartis Company Summary
Table 9. Novartis siRNA Drugs Product Offerings
Table 10. Sirnaomics Company Summary
Table 11. Sirnaomics siRNA Drugs Product Offerings
Table 12. Ribo Life Science Company Summary
Table 13. Ribo Life Science siRNA Drugs Product Offerings
Table 14. By Region? Global siRNA Drugs Revenue, (US$, Mn), 2024 & 2032
Table 15. By Region - Global siRNA Drugs Revenue, (US$, Mn), 2024-2032
Table 16. By Type ? Global siRNA Drugs Market Size, (US$, Mn), 2024 & 2032
Table 17. By Application? Global siRNA Drugs Market Size, (US$, Mn), 2024 & 2032
List of Figures
Figure 1. siRNA Drugs Segment by Type in 2032
Figure 2. siRNA Drugs Segment by Application in 2032
Figure 3. Global siRNA Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global siRNA Drugs Market Size: 2023 VS 2032 (US$, Mn)
Figure 6. Global siRNA Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. By Region - Global siRNA Drugs Revenue Market Share, 2024-2032
Figure 8. By Type - Global siRNA Drugs Revenue Market Share, 2024-2032
Figure 9. By Application - Global siRNA Drugs Revenue Market Share, 2024-2032
